(MENAFN- PR Newswire)
Zoom conference call scheduled for November 21, 2024, 9:00 AM ET
REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ --
Evogene Ltd . (Nasdaq: EVGN ) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024 .
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
To join the conference, please register in advance:
The entire conference will be available online on the company's website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq: EVGN , TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines - MicroBoost
AI, ChemPass AI
and
GeneRator AI. Each tech-engine
is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:
Biomica Ltd. ( )
- developing and advancing novel microbiome-based therapeutics to treat human disorders powered by
MicroBoost AI;
Lavie Bio Ltd. ( )
- developing and commercially advancing, microbiome-based ag-biologicals powered by
MicroBoost AI;
AgPlenus Ltd. ( ) - developing next-generation ag chemicals for effective and sustainable crop protection powered by
ChemPass AI;
Casterra Ag Ltd. ( ) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by
GeneRator AI.
For more information, please visit: .
Logo -
Contact
[email protected]
Tel: +972-8-9311901
SOURCE Evogene
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN07112024003732001241ID1108860941
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.